Quantification of naive and memory T-cell turnover during HIV-1 infection

AIDS

Volumn 29, Issue 16, 2015, Pages 2071-2080

  Vrisekoop, Nienke ^a   Drylewicz, Julia ^a,b   Van Gent, Rogier ^a,c   Mugwagwa, Tendai ^b,d   Van Lelyveld, Steven F L ^a,e   Veel, Ellen ^a   Otto, Sigrid A ^a   Ackermans, Mariëtte T ^f   Vermeulen, Joost N ^f   Huidekoper, Hidde H ^f   Prins, Jan M ^f   Miedema, Frank ^a   De Boer, Rob J ^b   Tesselaar, Kiki ^a   Borghans, José A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Department of Orthopaedic Surgery   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

HIV; labeling; lifespan; lymphocytes; mathematical modeling; stable isotope; T cells

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LABELING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VIVO STUDY; LONG TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE LIFESPAN; TURNOVER TIME; ADULT; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ISOLATION AND PURIFICATION; ISOTOPE LABELING; MALE; MIDDLE AGED; PHYSIOLOGY; T LYMPHOCYTE; THEORETICAL MODEL; VIROLOGY; YOUNG ADULT;

ADULT; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; ISOTOPE LABELING; MALE; MIDDLE AGED; MODELS, THEORETICAL; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84964893968     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000822     Document Type: Article

References (50)

1. Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, Miedema F, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81:8838-8842.
2. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narvaez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4R T-cell changes independent of viral load. Blood 2004; 104:942-947.
3. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870.
4. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881-1888.
5. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003; 18:441-452.
6. Ferguson NM, deWolf F, Ghani AC, Fraser C, Donnelly CA, Reiss P, et al. Antigen-driven CD4RT cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1999; 96:15167-15172.
7. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5:83-89.
8. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, Metcalf JA, et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 2001; 194:1731-1741.
9. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Sereti I, Sachau W, et al. Induction of prolonged survival of CD4R T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest 2005; 115:2139-2148.
10. Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4R and CD8R T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 2000; 97:13778-13783.
11. McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest 2000; 105:R1-R8.
12. Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194:1277-1287.
13. Perelson AS, Essunger P, Ho DD. Dynamics of HIV-1 and CD4R lymphocytes in vivo. AIDS 1997; 11 (Suppl A):S17-S24.
14. Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, Hirschel B, et al. Turnover of CD4R and CD8R T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 1998; 187:1295-1303.
15. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-2066.
16. Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, Neese RA, et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003; 112:956-966.
17. Combadere B, Blanc C, Li T, Carcelain G, Delaugerre C, Calvez V, et al. CD4RKi67R lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol 2000; 30:3598-3603.
18. Ladell K, Hellerstein MK, Cesar D, Busch R, Boban D, McCune JM. Central memory CD8R T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J Immunol 2008; 180:7907-7918.
19. Macallan DC, Asquith B, Irvine AJ, Wallace DL, Worth A, Ghattas H, et al. Measurement and modeling of human T cell kinetics. Eur J Immunol 2003; 33:2316-2326.
20. Macallan DC, Wallace D, Zhang Y, De LC, Worth AT, Ghattas H, et al. Rapid turnover of effector-memory CD4(R) T cells in healthy humans. J Exp Med 2004; 200:255-260.
21. Ribeiro RM, Mohri H, Ho DD, Perelson AS. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4R but not CD8R T cells depleted? Proc Natl Acad Sci U S A 2002; 99:15572-15577.
22. Vrisekoop N, den Braber I, de Boer AB, Ruiter AF, Ackermans MT, van der Crabben SN, et al. Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool. Proc Natl Acad Sci U S A 2008; 105:6115-6120.
23. Zhang Y, De Lara C, Worth A, Hegedus A, Laamanen K, Beverley P, et al. Accelerated in vivo proliferation of memory phenotype CD4(R) T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism. PLoS Pathog 2013; 9:e1003310.
24. Hegedus A, Nyamweya S, Zhang Y, Govind S, Aspinall R, Mashanova A, et al. Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics. J Infect Dis 2014; 210:752-761.
25. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-39.
26. Westera L, Zhang Y, Tesselaar K, Borghans JA, Macallan DC. Quantitating lymphocyte homeostasis in vivo in humans using stable isotope tracers. Methods Mol Biol 2013; 979:107-131.
27. Neese RA, Misell LM, Turner S, Chu A, Kim J, Cesar D, et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A 2002; 99:15345-15350.
28. Previs SF, Des RC, Beylot M, David F, Brunengraber H. Assay of the 13C and 2H mass isotopomer distribution of phosphoenolpyruvate by gas chromatography/mass spectrometry. J Mass Spectrom 1996; 31:643-648.
29. Ganusov V, Borghans JAM, De Boer RJ. Explicit kinetic heterogeneity: mathematical models for interpretation of deuterium labeling of heterogeneous cell populations. PLoS Comput Biol 2010; 6:e1000666.
30. Westera L, Drylewicz J, den Braber I, Mugwagwa T, van der Maas I, Kwast L, et al. Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood 2013; 122:2205-2212.
31. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95:249-255.
32. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nature Med 1999; 5:83-89.
33. De Boer RJ, Perelson AS. Quantifying T lymphocyte turnover. J Theor Biol 2013; 327:45-87.
34. Borghans JA, De Boer RJ. Quantification of T-cell dynamics: from telomeres to DNA labeling. Immunol Rev 2007; 216:35-47.
35. Ahmed R, Westera L, Drylewicz J, Elemans M, Zhang Y, Kelly E, et al. Reconciling estimates of cell proliferation from stable isotope labeling experiments. PLoS Comp Biol 2015 doi:10.1371/journal.pcbi.1004355.
36. Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, Kettaf N, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004; 21:757-768.
37. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-126.
38. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-79.
39. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, Akbar AN. IL-7-dependent extrathymic expansion of CD45RAR T cells enables preservation of a naive repertoire. J Immunol 1998; 161:5909-5917.
40. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin-7- treated naive T cells can be productively infected by T-celladapted and primary isolates of human immunodeficiency virus 1. Blood 2002; 99:3310-3318.
41. Srinivasula S, Lempicki RA, Adelsberger JW, Huang CY, Roark J, Lee PI, et al. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011; 118:262-270.
42. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
43. Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, Dolan MJ, et al. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen- presenting cells. Blood 2005; 105:2458-2464.
44. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008; 126:235-242.
45. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4R T cells go out of stock. Nat Immunol 2000; 1:285-289.
46. Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, De Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol 2013; 4:298.
47. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-695.
48. Hazenberg MD, Otto SA, Cohen Stuart JWT, Verschuren MCM, Borleffs JCC, Boucher CAB, et al. Increased cell division but not thymic dysfunction rapidly affects the TREC content of the naive T cell population in HIV-1 infection. Nat Med 2000; 6:1036-1042.
49. Berzins SP, Boyd RL, Miller JF. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med 1998; 187:1839-1848.
50. Berzins SP, Godfrey DI, Miller JF, Boyd RL. A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci U S A 1999; 96:9787-9791.